APO Research

APO RESEARCH · REPORT

Natural Immune Booster

Selected research

Market Outlook & Growth Opportunities

Global Natural Immune Booster Market Outlook and Growth Opportunities 2026

Market perspective

The global Natural Immune Booster market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Natural Immune Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Natural Immune Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Natural Immune Booster is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Natural Immune Booster market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Natural Immune Booster market include Specialty Biotech, Royal DSM, Lallemand, Chr. Hansen, Biotec Pharmacon, Angel Yeast and AB Mauri, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Natural Immune Booster market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Natural Immune Booster and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Natural Immune Booster sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natural Immune Booster market size, projected growth trends, production technologies, key applications, and end-use industries.

Natural Immune Booster Segment by Company

Specialty Biotech

Royal DSM

Lallemand

Chr. Hansen

Biotec Pharmacon

Angel Yeast

AB Mauri

Natural Immune Booster Segment by Type

Yeast Extract

Yeast Beta

Others

Natural Immune Booster Segment by Application

Beverages

Pharmaceuticals

Dairy Products

Bakery & Processed Food

Others

Natural Immune Booster Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Natural Immune Booster status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Natural Immune Booster market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Natural Immune Booster significant trends, drivers, influence factors in global and regions.

6. To analyze Natural Immune Booster competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Immune Booster market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natural Immune Booster and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Immune Booster.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Natural Immune Booster market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Natural Immune Booster industry.

Chapter 3: Detailed analysis of Natural Immune Booster manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Natural Immune Booster in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Natural Immune Booster in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Natural Immune Booster Industry Trends Table 2. Natural Immune Booster Industry Drivers Table 3. Natural Immune Booster Industry Opportunities and Challenges Table 4. Natural Immune Booster Industry Restraints Table 5. Global Natural Immune Booster Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Natural Immune Booster Revenue Share by Company (2021-2026) Table 7. Global Natural Immune Booster Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Natural Immune Booster Sales Volume Share by Company (2021-2026) Table 9. Global Natural Immune Booster Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Natural Immune Booster Company Ranking, (2024-2026) & (USD Million) Table 11. Global Natural Immune Booster Key Company Manufacturing Base & Headquarters Table 12. Global Natural Immune Booster Company, Product Type & Application Table 13. Global Natural Immune Booster Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Natural Immune Booster by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Yeast Extract Table 18. Significant Companies of Yeast Beta Table 19. Significant Companies of Others Table 20. Global Natural Immune Booster Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Natural Immune Booster Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Natural Immune Booster Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Natural Immune Booster Sales Volume Share by Type (2021-2026) Table 24. Global Natural Immune Booster Sales Volume Share by Type (2027-2032) Table 25. Global Natural Immune Booster Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Natural Immune Booster Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Natural Immune Booster Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Natural Immune Booster Sales Value Share by Type (2021-2026) Table 29. Global Natural Immune Booster Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Beverages Table 31. Significant Companies of Pharmaceuticals Table 32. Significant Companies of Dairy Products Table 33. Significant Companies of Bakery & Processed Food Table 34. Significant Companies of Others Table 35. Global Natural Immune Booster Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Natural Immune Booster Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Natural Immune Booster Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Natural Immune Booster Sales Volume Share by Application (2021-2026) Table 39. Global Natural Immune Booster Sales Volume Share by Application (2027-2032) Table 40. Global Natural Immune Booster Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Natural Immune Booster Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Natural Immune Booster Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Natural Immune Booster Sales Value Share by Application (2021-2026) Table 44. Global Natural Immune Booster Sales Value Share by Application (2027-2032) Table 45. Global Natural Immune Booster Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Natural Immune Booster Sales by Region (2021-2026) & (K Units) Table 47. Global Natural Immune Booster Sales Market Share by Region (2021-2026) Table 48. Global Natural Immune Booster Sales by Region (2027-2032) & (K Units) Table 49. Global Natural Immune Booster Sales Market Share by Region (2027-2032) Table 50. Global Natural Immune Booster Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Natural Immune Booster Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Natural Immune Booster Sales Value Share by Region (2021-2026) Table 53. Global Natural Immune Booster Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Natural Immune Booster Sales Value Share by Region (2027-2032) Table 55. Global Natural Immune Booster Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Natural Immune Booster Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Natural Immune Booster Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Natural Immune Booster Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Natural Immune Booster Sales by Country (2021-2026) & (K Units) Table 60. Global Natural Immune Booster Sales Market Share by Country (2021-2026) Table 61. Global Natural Immune Booster Sales by Country (2027-2032) & (K Units) Table 62. Global Natural Immune Booster Sales Market Share by Country (2027-2032) Table 63. Global Natural Immune Booster Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Natural Immune Booster Sales Value Market Share by Country (2021-2026) Table 65. Global Natural Immune Booster Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Natural Immune Booster Sales Value Market Share by Country (2027-2032) Table 67. Specialty Biotech Company Information Table 68. Specialty Biotech Business Overview Table 69. Specialty Biotech Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Specialty Biotech Natural Immune Booster Product Portfolio Table 71. Specialty Biotech Recent Development Table 72. Royal DSM Company Information Table 73. Royal DSM Business Overview Table 74. Royal DSM Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Royal DSM Natural Immune Booster Product Portfolio Table 76. Royal DSM Recent Development Table 77. Lallemand Company Information Table 78. Lallemand Business Overview Table 79. Lallemand Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Lallemand Natural Immune Booster Product Portfolio Table 81. Lallemand Recent Development Table 82. Chr. Hansen Company Information Table 83. Chr. Hansen Business Overview Table 84. Chr. Hansen Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Chr. Hansen Natural Immune Booster Product Portfolio Table 86. Chr. Hansen Recent Development Table 87. Biotec Pharmacon Company Information Table 88. Biotec Pharmacon Business Overview Table 89. Biotec Pharmacon Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Biotec Pharmacon Natural Immune Booster Product Portfolio Table 91. Biotec Pharmacon Recent Development Table 92. Angel Yeast Company Information Table 93. Angel Yeast Business Overview Table 94. Angel Yeast Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Angel Yeast Natural Immune Booster Product Portfolio Table 96. Angel Yeast Recent Development Table 97. AB Mauri Company Information Table 98. AB Mauri Business Overview Table 99. AB Mauri Natural Immune Booster Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. AB Mauri Natural Immune Booster Product Portfolio Table 101. AB Mauri Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Natural Immune Booster Distributors List Table 105. Natural Immune Booster Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Natural Immune Booster Product Image Figure 2. Global Natural Immune Booster Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 4. Global Natural Immune Booster Sales (2021-2032) & (K Units) Figure 5. Global Natural Immune Booster Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Natural Immune Booster Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Yeast Extract Image Figure 10. Yeast Beta Image Figure 11. Others Image Figure 12. Global Natural Immune Booster Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Natural Immune Booster Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Natural Immune Booster Sales Volume Share by Type (2021-2032) Figure 15. Global Natural Immune Booster Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Natural Immune Booster Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Natural Immune Booster Sales Value Share by Type (2021-2032) Figure 18. Beverages Image Figure 19. Pharmaceuticals Image Figure 20. Dairy Products Image Figure 21. Bakery & Processed Food Image Figure 22. Others Image Figure 23. Global Natural Immune Booster Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Natural Immune Booster Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Natural Immune Booster Sales Volume Share by Application (2021-2032) Figure 26. Global Natural Immune Booster Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Natural Immune Booster Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Natural Immune Booster Sales Value Share by Application (2021-2032) Figure 29. Global Natural Immune Booster Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Natural Immune Booster Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Natural Immune Booster Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Natural Immune Booster Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 34. North America Natural Immune Booster Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Natural Immune Booster Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Natural Immune Booster Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 40. South America Natural Immune Booster Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Natural Immune Booster Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Natural Immune Booster Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Natural Immune Booster Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Natural Immune Booster Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Natural Immune Booster Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Natural Immune Booster Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Natural Immune Booster Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Extract
  • Yeast Beta
  • Others
Applications
  • Beverages
  • Pharmaceuticals
  • Dairy Products
  • Bakery & Processed Food
  • Others
Companies covered
  • Specialty Biotech
  • Royal DSM
  • Lallemand
  • Chr. Hansen
  • Biotec Pharmacon
  • Angel Yeast
  • AB Mauri

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Natural Immune Booster Sales Value (2021-2032)
  4. 1.2.2 Global Natural Immune Booster Sales Volume (2021-2032)
  5. 1.2.3 Global Natural Immune Booster Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Natural Immune Booster Market Dynamics
  1. 2.1 Natural Immune Booster Industry Trends
  2. 2.2 Natural Immune Booster Industry Drivers
  3. 2.3 Natural Immune Booster Industry Opportunities and Challenges
  4. 2.4 Natural Immune Booster Industry Restraints
3 Natural Immune Booster Market by Company
  1. 3.1 Global Natural Immune Booster Company Revenue Ranking in 2025
  2. 3.2 Global Natural Immune Booster Revenue by Company (2021-2026)
  3. 3.3 Global Natural Immune Booster Sales Volume by Company (2021-2026)
  4. 3.4 Global Natural Immune Booster Average Price by Company (2021-2026)
  5. 3.5 Global Natural Immune Booster Company Ranking (2024-2026)
  6. 3.6 Global Natural Immune Booster Company Manufacturing Base and Headquarters
  7. 3.7 Global Natural Immune Booster Company Product Type and Application
  8. 3.8 Global Natural Immune Booster Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Natural Immune Booster Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Natural Immune Booster Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Natural Immune Booster Market by Type
  1. 4.1 Natural Immune Booster Type Introduction
  2. 4.1.1 Yeast Extract
  3. 4.1.2 Yeast Beta
  4. 4.1.3 Others
  5. 4.2 Global Natural Immune Booster Sales Volume by Type
  6. 4.2.1 Global Natural Immune Booster Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Natural Immune Booster Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Natural Immune Booster Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Natural Immune Booster Sales Value by Type
  10. 4.3.1 Global Natural Immune Booster Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Natural Immune Booster Sales Value by Type (2021-2032)
  12. 4.3.3 Global Natural Immune Booster Sales Value Share by Type (2021-2032)
5 Natural Immune Booster Market by Application
  1. 5.1 Natural Immune Booster Application Introduction
  2. 5.1.1 Beverages
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Dairy Products
  5. 5.1.4 Bakery & Processed Food
  6. 5.1.5 Others
  7. 5.2 Global Natural Immune Booster Sales Volume by Application
  8. 5.2.1 Global Natural Immune Booster Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Natural Immune Booster Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Natural Immune Booster Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Natural Immune Booster Sales Value by Application
  12. 5.3.1 Global Natural Immune Booster Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Natural Immune Booster Sales Value by Application (2021-2032)
  14. 5.3.3 Global Natural Immune Booster Sales Value Share by Application (2021-2032)
6 Natural Immune Booster Regional Sales and Value Analysis
  1. 6.1 Global Natural Immune Booster Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Natural Immune Booster Sales by Region (2021-2032)
  3. 6.2.1 Global Natural Immune Booster Sales by Region: 2021-2026
  4. 6.2.2 Global Natural Immune Booster Sales by Region (2027-2032)
  5. 6.3 Global Natural Immune Booster Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Natural Immune Booster Sales Value by Region (2021-2032)
  7. 6.4.1 Global Natural Immune Booster Sales Value by Region: 2021-2026
  8. 6.4.2 Global Natural Immune Booster Sales Value by Region (2027-2032)
  9. 6.5 Global Natural Immune Booster Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Natural Immune Booster Sales Value (2021-2032)
  12. 6.6.2 North America Natural Immune Booster Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Natural Immune Booster Sales Value (2021-2032)
  15. 6.7.2 Europe Natural Immune Booster Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Natural Immune Booster Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Natural Immune Booster Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Natural Immune Booster Sales Value (2021-2032)
  21. 6.9.2 South America Natural Immune Booster Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Natural Immune Booster Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Natural Immune Booster Sales Value Share by Country, 2025 VS 2032
7 Natural Immune Booster Country-level Sales and Value Analysis
  1. 7.1 Global Natural Immune Booster Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Natural Immune Booster Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Natural Immune Booster Sales by Country (2021-2032)
  4. 7.3.1 Global Natural Immune Booster Sales by Country (2021-2026)
  5. 7.3.2 Global Natural Immune Booster Sales by Country (2027-2032)
  6. 7.4 Global Natural Immune Booster Sales Value by Country (2021-2032)
  7. 7.4.1 Global Natural Immune Booster Sales Value by Country (2021-2026)
  8. 7.4.2 Global Natural Immune Booster Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Natural Immune Booster Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Natural Immune Booster Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Natural Immune Booster Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Natural Immune Booster Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Natural Immune Booster Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Natural Immune Booster Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Natural Immune Booster Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Natural Immune Booster Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Natural Immune Booster Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Natural Immune Booster Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Natural Immune Booster Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Natural Immune Booster Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Natural Immune Booster Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Natural Immune Booster Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Natural Immune Booster Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Natural Immune Booster Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Natural Immune Booster Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Natural Immune Booster Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Natural Immune Booster Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Natural Immune Booster Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Natural Immune Booster Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Natural Immune Booster Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Natural Immune Booster Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Natural Immune Booster Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Natural Immune Booster Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Natural Immune Booster Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Natural Immune Booster Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Natural Immune Booster Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Natural Immune Booster Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Natural Immune Booster Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Specialty Biotech
  2. 8.1.1 Specialty Biotech Company Information
  3. 8.1.2 Specialty Biotech Business Overview
  4. 8.1.3 Specialty Biotech Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Specialty Biotech Natural Immune Booster Product Portfolio
  6. 8.1.5 Specialty Biotech Recent Developments
  7. 8.2 Royal DSM
  8. 8.2.1 Royal DSM Company Information
  9. 8.2.2 Royal DSM Business Overview
  10. 8.2.3 Royal DSM Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Royal DSM Natural Immune Booster Product Portfolio
  12. 8.2.5 Royal DSM Recent Developments
  13. 8.3 Lallemand
  14. 8.3.1 Lallemand Company Information
  15. 8.3.2 Lallemand Business Overview
  16. 8.3.3 Lallemand Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lallemand Natural Immune Booster Product Portfolio
  18. 8.3.5 Lallemand Recent Developments
  19. 8.4 Chr. Hansen
  20. 8.4.1 Chr. Hansen Company Information
  21. 8.4.2 Chr. Hansen Business Overview
  22. 8.4.3 Chr. Hansen Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Chr. Hansen Natural Immune Booster Product Portfolio
  24. 8.4.5 Chr. Hansen Recent Developments
  25. 8.5 Biotec Pharmacon
  26. 8.5.1 Biotec Pharmacon Company Information
  27. 8.5.2 Biotec Pharmacon Business Overview
  28. 8.5.3 Biotec Pharmacon Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biotec Pharmacon Natural Immune Booster Product Portfolio
  30. 8.5.5 Biotec Pharmacon Recent Developments
  31. 8.6 Angel Yeast
  32. 8.6.1 Angel Yeast Company Information
  33. 8.6.2 Angel Yeast Business Overview
  34. 8.6.3 Angel Yeast Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Angel Yeast Natural Immune Booster Product Portfolio
  36. 8.6.5 Angel Yeast Recent Developments
  37. 8.7 AB Mauri
  38. 8.7.1 AB Mauri Company Information
  39. 8.7.2 AB Mauri Business Overview
  40. 8.7.3 AB Mauri Natural Immune Booster Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AB Mauri Natural Immune Booster Product Portfolio
  42. 8.7.5 AB Mauri Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Natural Immune Booster Value Chain Analysis
  2. 9.1.1 Natural Immune Booster Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Natural Immune Booster Sales Mode & Process
  6. 9.2 Natural Immune Booster Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Natural Immune Booster Distributors
  9. 9.2.3 Natural Immune Booster Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research